From: Maternal drug use and the risk of anorectal malformations: systematic review and meta-analysis
 | Maternal use of drugs against nausea and vomiting |  | |||
---|---|---|---|---|---|
Ref. | First author, year | Exposure | ORcrude [95% CI] | ORadj [95% CI] | Adjustment/matching factors |
[49] | Pasternak, 2013 | Metoclopramide | 0.7 [0.34, 1.54]c | 0.8 [0.36, 1.66]b | Matched and adjusted for hospitalization for hyperemesis gravidarum or nausea and vomiting, and use of other antiemetics in the first trimester |
[78] | Källén and Mottet, 2003 | Meclozine | 2.3 [0.99, 4.50]a | – | – |